U.S. Heparin Market 2021: Latest Development & Trends Forecast To 2026

U.S heparin market is highly characterized by the online pharmacy segment, which according to numerous reports is estimated to grow exponentially over the upcoming years owing to the numerous benefits associated with it such as availability of a wide range of products, discounts, easy mobilization and doorstep delivery. Such benefits are likely to attract a large consumer base. Moreover, the increasing adoption of online shopping among the young population will further support segment growth. For the records, the segment had registered a sizeable market share of over 13.4% in 2019.

The rising burden of chronic diseases and conditions with blood clot formation across the United States have indeed offered a prolific surge to the adoption of anticoagulant drugs, thus stimulating the overall outlook of the U.S heparin market over the span of 2020 to 2026. Introduced in 1970s, the anticoagulant drug is considered to be widely used in the United States, allowing the overall industry to grow at a CAGR of 7.2% through 2026 while accounting for a revenue share of USD 1 billion over the stipulated time frame.

Get sample copy of this research report @ https://www.decresearch.com/request-sample/detail/4868

In terms of product, the low molecular weight heparin segment accounted for a substantial valuation of USD 535.4 million in the past and is anticipated to dominate the market over the subsequent years. This can be attributed to the extensive use of low molecular weight heparin in coagulation disorders treatment as well as in surgical procedures. Besides, the increasing prevalence of deep vein thrombosis (DVT) will also impel the demand for low molecular weight heparin. In addition, elevating product demand across several healthcare settings on account of the increasing burden of chronic and cardiovascular diseases will complement the segment growth further.

Based on the application spectrum, the coronary artery disease segment had recorded an appreciable valuation of USD 148.5 million in 2019 and is expected to grow over time. The growth can be credited to increasing demand for heparin treatment due to the rising incidence of coronary artery disease in the country. Based on a report by the Center for Disease Control and Prevention, coronary heart disease (CAD) is the most common heart disease in U.S., resulting in around 365,914 deaths in 2017. Further, the report also mentions that over 18.2 million adults in the age group of 20 years and above are suffering from CAD.

Apart from the above-mentioned segments and the growth inducing factors associated with them, strategic initiatives undertaken by the business players are also significantly contributing to the industry growth. Prominent industry players operating in U.S heparin market such as Amphastar Pharmaceutical, Pfizer, Sanofi, Fresenius Kabi, Shenzhen Hepalink, etc. are focusing on strategic partnerships, acquisitions, geographical expansion and new product launches to strengthen their market position.

In a recent turn of events, one of the prominent drug companies- Fresenius Kabi- in 2019 announced the launch of heparin sodium injection, USP Simplist Prefilled Syringe in 5000 USP units per 0.5mL presentation in the provinces of United States. This novel launch was entitled to support the company’s motive of standing a level apart in the overall U.S heparin market.

Request for a Customization of this research report @ https://www.decresearch.com/roc/4868

Partial Chapter of the Table of Content

Chapter 4   U.S Heparin Market, By Product

  • 4.1    Key segment trends
  • 4.2    Low molecular weight heparin
  • 4.2.1    Market size, 2015 - 2026 (USD Million)
  • 4.3    Unfractionated heparin
  • 4.3.1    Market size, 2015 - 2026 (USD Million)

Chapter 5   U.S Heparin Market, By Application

  • 5.1    Key segment trends
  • 5.2    Venous thromboembolism
  • 5.2.1    Market size, 2015 - 2026 (USD Million)
  • 5.3    Atrial fibrillation/flutter
  • 5.3.1    U.S Heparin Market size, 2015 - 2026 (USD Million)
  • 5.4    Coronary artery disease
  • 5.4.1    Market size, 2015 - 2026 (USD Million)
  • 5.5    Others
  • 5.5.1    Market size, 2015 - 2026 (USD Million)

Chapter 6   U.S Heparin Market, By Distribution Channel

  • 6.1    Key segment trends
  • 6.2    Hospital pharmacy
  • 6.2.1    Market size, 2015 - 2026 (USD Million)
  • 6.3    Retail pharmacy
  • 6.3.1    Market size, 2015 - 2026 (USD Million)
  • 6.4    Online pharmacy
  • 6.4.1    U.S Heparin Market size, 2015 - 2026 (USD Million)

Browse complete Table of Contents (ToC) of this research report @ https://www.decresearch.com/toc/detail/us-heparin-market

Browse Related Report: -

Display Market Size By Application (ATM [By Display Size {7”, 8”, 10”, Above 10”}, By Resolution {700x340 pixels, 800x600 pixels}], POS Terminals [By Display Size {10”, 12”, 15”, 17”, 19”, 20”}, By Resolution {1024x768 pixels, 1366x768 pixels, 1280x800 pixels}], Kiosks [By Display Size {15” – 17”, 17” – 32”, 32” – 65”, Above 65”}, By Resolution {1024x768 pixels, 1280x1024 pixels, 1920x1080 pixels}]), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2017 – 2024